---
title: "002737.SZ (002737.SZ) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/002737.SZ/news.md"
symbol: "002737.SZ"
name: "002737.SZ"
parent: "https://longbridge.com/zh-CN/quote/002737.SZ.md"
datetime: "2026-03-17T14:06:47.236Z"
locales:
  - [en](https://longbridge.com/en/quote/002737.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002737.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002737.SZ/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/002737.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002737.SZ/news.md)


# 002737.SZ (002737.SZ) — 相关新闻

### [The Guanshi family from Northeast China falls from the peak of children's medicine](https://longbridge.com/zh-CN/news/279363162.md)
*2026-03-17T03:38:36.000Z*
> The Sunflower Pharmaceutical of the Guanshi family in Northeast China has experienced both the brilliance and difficulti

### [Behind the first loss after going public: Why did SFPM choose to actively "squeeze out the excess"?](https://longbridge.com/zh-CN/news/278315393.md)
*2026-03-09T02:42:33.000Z*
> SFPM expects to report its first annual loss in 2025, with losses ranging between 240 million yuan and 380 million yuan.

### [SFPM: Appointed Wang Xifeng as the assistant general manager of the company](https://longbridge.com/zh-CN/news/277897603.md)
*2026-03-05T07:45:37.000Z*
> SFPM announced that the company will hold the 18th meeting of the fifth board of directors on March 5, 2026, to review a

### [21 days, two turns! Guan Yi "resigns as CEO and is promoted to vice president," hinting at the breakthrough code of SFPM](https://longbridge.com/zh-CN/news/277864680.md)
*2026-03-05T02:08:52.000Z*
> The core executive of SFPM, Guan Yi, has undergone two position changes within 21 days: resigning from the position of g

### [SFPM: Xuanju Guanyi elected as the vice chairman of the fifth board of directors](https://longbridge.com/zh-CN/news/277423998.md)
*2026-03-02T07:48:49.000Z*
> SFPM announced that the company will hold the 17th meeting of the fifth board of directors on March 2, 2026, to review a

### [SFPM: Compound Polyethylene Glycol (3350) Electrolyte Oral Solution Obtains Drug Registration Certificate](https://longbridge.com/zh-CN/news/276700116.md)
*2026-02-24T07:54:08.000Z*
> SFPM announced that its subsidiary recently obtained the drug registration certificate for Compound Polyethylene Glycol 

### [Healthcare Industry Daily (02.12): Pharmaceutical Industry Trends](https://longbridge.com/zh-CN/news/275798929.md)
*2026-02-12T19:14:16.000Z*
> HITECK plans to acquire a 23.08% stake in Beijing Shadong, increasing its shareholding to 98.84%, paving the way for the

### [Before the term ended, SFPM's "second-generation pharmaceutical" resigned from the positions of General Manager and President](https://longbridge.com/zh-CN/news/275456544.md)
*2026-02-10T12:09:55.000Z*
> On February 9th, Guo Yi, the general manager of SFPM, applied for resignation, leaving 16 months in advance, but still s

### [SFPM: Continuously increasing resource investment in the big health field, building an "online-first + omnichannel coverage" operational system](https://longbridge.com/zh-CN/news/275226210.md)
*2026-02-08T11:17:37.000Z*
> On February 8th, SFPM (002737) disclosed the investor relations activity record showing that the company received a rese